Antifungal Activities of R-135853, a Sordarin Derivative, in Experimental Candidiasis in Mice

Documenti analoghi

• Antifungal Activities of R-135853, a Sordarin Derivative, in Experimental Candidiasis in Mice
  di: Kamai, Yasuki, et al.
  Pubblicazione: (2005)
• Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice
  di: Kamai, Yasuki, et al.
  Pubblicazione: (2003)
• Antifungal Efficacy of GM237354, a Sordarin Derivative, in Experimental Oral Candidiasis in Immunosuppressed Rats
  di: Martinez, Antonio, et al.
  Pubblicazione: (2001)
• In Vitro and In Vivo Activities of CS-758 (R-120758), a New Triazole Antifungal Agent
  di: Kamai, Yasuki, et al.
  Pubblicazione: (2002)
• Contribution of Candida albicans ALS1 to the Pathogenesis of Experimental Oropharyngeal Candidiasis
  di: Kamai, Yasuki, et al.
  Pubblicazione: (2002)